[1] Shiliang Ji, Feifan Wang, Yongjie Wu, Haoran Hu, Zhen Xing, Jie Zhu, Shi Xu, Tiyun Han, Guilai Liu, Zengding Wu, Caiyi Fei, Lingming Kong, Jiangning Chen, Zhi Ding*, Zhen Huang*, Junfeng Zhang*. Large-scale transcript variants dictate neoepitopes for cancer immunotherapy. Sci Adv. 2025;11(5):eado5600.
[2] Mingming Zhao, Xiaohui Cheng, Pingwen Shao, Yao Dong, Yongjie Wu, Lin Xiao, Zhiying Cui, Xuedi Sun, Chuancheng Gao, Jiangning Chen*, Zhen Huang*, Junfeng Zhang*. Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapy. Nat Commun. 2024;15(1):950.
[3] Xiaohui Cheng, Pingwen Shao, XinTong Wang, Juan Jiang, Jiahui Chen, Jie Zhu, Weiming Zhu, Yi Li*, Junfeng Zhang*, Jiangning Chen*, Zhen Huang*. Myeloid-Derived Suppressor Cell Accumulation Drives Intestinal Fibrosis through mCCL6/hCCL15 Chemokine-Mediated Fibroblast Activation. Adv Sci (Weinh). 2024:e2411711.
[4] Chen Wang, Ziyu Shi, Yuqian Zhang, Mingyue Li , Jie Zhu, Zhen Huang*, Junfeng Zhang*, Jiangning Chen*. CBFβ promotes colorectal cancer progression through transcriptionally activating OPN, FAM129A, and UPP1 in a RUNX2-dependent manner. Cell Death Differ. 2021;28(11):3176-3192.
[5] Zhen Huang, Tongguo Shi, Qian Zhou, Song Shi, Ran Zhao, Hao Shi, Lei Dong, Chenyu Zhang, Ke Zeng, Jiangning Chen, Junfeng Zhang. MiR-141 Regulates colonic leukocytic trafficking by targeting CXCL12beta during murine colitis and human Crohn's disease. Gut. 63:1247-57, 2014.